433 related articles for article (PubMed ID: 1705190)
1. Histochemical localization of calcium with potassium pyroantimonate in the articular tissues in calcium pyrophosphate dihydrate crystal deposition disease.
Ohira T; Ishikawa K
Clin Orthop Relat Res; 1991 Mar; (264):286-94. PubMed ID: 1705190
[TBL] [Abstract][Full Text] [Related]
2. A histologic and immunohistochemical study of calcium pyrophosphate dihydrate crystal deposition disease.
Masuda I; Ishikawa K; Usuku G
Clin Orthop Relat Res; 1991 Feb; (263):272-87. PubMed ID: 1993383
[TBL] [Abstract][Full Text] [Related]
3. Histologic localization of lipid in the articular tissues in calcium pyrophosphate dihydrate crystal deposition disease.
Ohira T; Ishikawa K; Masuda I; Yokoyama M; Honda I
Arthritis Rheum; 1988 Aug; 31(8):1057-62. PubMed ID: 2457374
[TBL] [Abstract][Full Text] [Related]
4. Cartilage intermediate layer protein expression in calcium pyrophosphate dihydrate crystal deposition disease.
Yamakawa K; Iwasaki H; Masuda I; Ohjimi Y; Honda I; Iyama K; Shono E; Naito M; Kikuchi M
J Rheumatol; 2002 Aug; 29(8):1746-53. PubMed ID: 12180739
[TBL] [Abstract][Full Text] [Related]
5. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
Hirose J; Ryan LM; Masuda I
Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
[TBL] [Abstract][Full Text] [Related]
6. A histological study of calcium pyrophosphate dihydrate crystal-deposition disease.
Ishikawa K; Masuda I; Ohira T; Yokoyama M
J Bone Joint Surg Am; 1989 Jul; 71(6):875-86. PubMed ID: 2545720
[TBL] [Abstract][Full Text] [Related]
7. Calcium pyrophosphate crystal deposition in hyaline cartilage. Ultrastructural analysis and implications for pathogenesis.
Pritzker KP; Cheng PT; Renlund RC
J Rheumatol; 1988; 15(5):828-35. PubMed ID: 2845077
[TBL] [Abstract][Full Text] [Related]
8. An ultrastructural study of the articular cartilage in calcium pyrophosphate dihydrate (CPPD) crystal deposition disease (chondrocalcinosis articularis).
Bjelle AO; Sundström KG
Calcif Tissue Res; 1975 Nov; 19(1):63-71. PubMed ID: 172199
[TBL] [Abstract][Full Text] [Related]
9. [Identification of the crystals observed in the destructive arthropathies of chondrocalcinosis].
Gaucher A; Faure G; Netter P; Pourel J; Duheille J
Rev Rhum Mal Osteoartic; 1977 Jun; 44(6):407-14. PubMed ID: 882816
[TBL] [Abstract][Full Text] [Related]
10. The utility of alizarin red s staining in calcium pyrophosphate dihydrate crystal deposition disease.
Yamakawa K; Iwasaki H; Masuda I; Ohjimi Y; Honda I; Saeki K; Zhang J; Shono E; Naito M; Kikuchi M
J Rheumatol; 2003 May; 30(5):1032-5. PubMed ID: 12734902
[TBL] [Abstract][Full Text] [Related]
11. Contribution of calcium-containing crystals to cartilage degradation and synovial inflammation in osteoarthritis.
Liu YZ; Jackson AP; Cosgrove SD
Osteoarthritis Cartilage; 2009 Oct; 17(10):1333-40. PubMed ID: 19447216
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of ANK protein expression in joint tissue in calcium pyrophosphate dihydrate crystal deposition disease.
Uzuki M; Sawai T; Ryan LM; Rosenthal AK; Masuda I
J Rheumatol; 2014 Jan; 41(1):65-74. PubMed ID: 24293574
[TBL] [Abstract][Full Text] [Related]
13. [Scanning electron microscopic observations of calcium pyrophosphate crystals of joint tissues and synovial fluid (author's transl)].
Nagahashi M
Nihon Seikeigeka Gakkai Zasshi; 1979 Jul; 53(7):793-805. PubMed ID: 227973
[TBL] [Abstract][Full Text] [Related]
14. Calcium pyrophosphate crystal deposition disease and other crystal deposition diseases.
Fam AG
Curr Opin Rheumatol; 1992 Aug; 4(4):574-82. PubMed ID: 1503884
[TBL] [Abstract][Full Text] [Related]
15. [Calcium pyrophosphate dihydrate-crystal induced arthropathy].
Schneider Internist-Rheumatologe Chefarzt Der Abteilung Für Rheumatologie P; Schneider I
Z Rheumatol; 2004 Feb; 63(1):10-21. PubMed ID: 14991274
[TBL] [Abstract][Full Text] [Related]
16. Hypomagnesemia and chondrocalcinosis in short bowel syndrome.
Richette P; Ayoub G; Bardin T; Bouvet S; Orcel P; Badran AM
J Rheumatol; 2005 Dec; 32(12):2434-6. PubMed ID: 16331778
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of crystals within the joint.
Oliviero F; Scanu A; Punzi L
Reumatismo; 2012 Jan; 63(4):221-9. PubMed ID: 22303528
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease.
So PP; Tsui FW; Vieth R; Tupy JH; Pritzker KP
J Rheumatol; 2007 Jun; 34(6):1313-22. PubMed ID: 17516619
[TBL] [Abstract][Full Text] [Related]
19. [Chondrocalcinosis].
Fallet GH; Vischer TL; Micheli A
Schweiz Med Wochenschr; 1982 Jun; 112(25):888-97. PubMed ID: 7112058
[TBL] [Abstract][Full Text] [Related]
20. Ferrous [Fe++] but not ferric [Fe] ions inhibit de novo formation of calcium pyrophosphate dihydrate crystals: possible relationships to chondrocalcinosis and hemochromatosis.
Cheng PT; Pritzker KP
J Rheumatol; 1988 Feb; 15(2):321-4. PubMed ID: 2834554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
